24СʱÈÈÃŰæ¿éÅÅÐаñ    

²é¿´: 3134  |  »Ø¸´: 1

pxiao08

Ìú³æ (³õÈëÎÄ̳)

[ÇóÖú] ½ô¼±ÇóÖú£¡ÎÄÕÂacceptºóÌîд·¢±íͬÒâÊ飨PUBLISHING AGREEMENT£©µÄÎÊÌâ

¸÷λվÓÑ£¬±¾ÈËͶ¸åÁËһƪSAGEÆìÏÂÆÚ¿¯£¬ÏÖÒÑACCEPTED¡£ÔÚÌîдJOURNAL CONTRIBUTOR'S PUBLISHING AGREEMENT¹ý³ÌÖгöÏÖÁËһЩ¸öÈ˲»Àí½âµÄÎÊÌ⣬Çë¸÷λ´Í½Ì¡£²»Ê¤¸Ðл£¡£¡£¡

2. Declaration of Conflict of Interest and Financial Disclosure:

Contributors certify that the answers below are a thorough and accurate representation of all potential conflicts of interest of each Contributor and disclosure of full and complete financial support information relating to the Contribution:

1. The Contributors, either individually or collectively, have received financial support, including pharmaceutical company support, authorship or promotion of the Contribution.         Yes          No
In the box provided, enter a list and description of all forms and sources of financial support that each Contributor received related to the Contribution, including for each Contributor: a) the name of the supporting organization, b) the interests it represents and/or its product discussed or alluded to within the Contribution, and c) all Contributors who received support:
ÎÊÌâ1. ÊÇÒªÌî»ù½ð×ÊÖúÏîÄ¿Â𣿱ÈÈç×ÔÈ»¿ÆÑ§»ù½ð×ÊÖúÁ˱¾Ñо¿£¨ÎÒͶ¸åµÄ¸½¼þÀïҲдÁË£©£¬ÕâÀﻹҪдÂð£¿
ÎÊÌâ2. Èç¹ûÒªÌîдµÄ»°£¬ÊÇÌîÔÚËüÒªÇóµÄ¿òÀÄÚÈÝÔõôÌîÄØ£¿Êǰ´ÕÕÏÂÃæµÄ¸ñʽÂð£¿
a£¬Õⲿ·ÖÊÇÌî  ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð£¿
b£¬Õⲿ·ÖÔõôÌîÄØ£¿ÊÇÌîдNo potential conflict of interest relevant to this articleÂð£¿
c£¬Õⲿ·ÖÊÇÕâÑùÌîÂð£¿xx£¨±ÈÈçÎÒ£©received ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðµÄ×ÊÖú¡£
ÉÏÃæÕâ¸ö²¿·Ö
   



2. The Contributors, either individually or collectively, have commercial or financial involvements that might present an appearance of a conflict of interest related to the Contribution.         Yes          No
In the box provided, enter a list and description of all forms of commercial or financial involvements of each Contributor who received support:
ÎÒÕâÆªÎÄÕÂÖ»ÊÇÊܵ½Èç¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðºÍÎÒÃÇѧУ»ù½ðµÄ×ÊÖú£¬ÄÇôÕⲿ·ÖÔõôÌîÄØ£¿¿ÉÄܻᵼÖÂ·ÖÆçµÄÉÌÒµ»ò²ÆÕþ×ÊÖú£¿ÊÇʲôÒâ˼£¿

   

3. Contributors, either individually or collectively, have signed agreements with sponsors of the research reported in the Contribution that places any requirements on their publication of the research findings, such as preventing them from publishing both positive and negative results or that forbids them from publishing the research without the prior approval of the sponsor.
Yes          No
In the box provided, enter a list and description of all sponsor agreements for each Contributor, including a description of any publication requirements:Õⲿ·ÖÊÇÒªÌîÊ²Ã´ÄØ£¿ÊDz»ÊÇһЩҩÎïÊÔÑéµÄÑо¿²ÅÒªÌîÐ´ÄØ£¿£¨ÑôÐÔÒõÐÔ½á¹û£¬Ò©³§²»È÷¢²¼£©ÎÒÕâÆªÎÄÕºÃÏñ²»Éæ¼°µ½Õâ¸ö·½Ã棬¾ÍÊÇÒ»¸öÁ÷Ðв¡Ñ§µÄµ÷²é¡£
Çë¸÷λսÓÑÖ¸µã£¡



xxÔÓÖ¾ reserves the right to include any information provided by Contributors in the sections above within the published Contribution as part of the Financial Disclosure Statement. If no conflicts of interest are declared, then the following statement may be printed with the Contribution: ¡®The Authors declared that they had no conflicts of interests in their authorship and publication of this Contribution.¡¯   Õâ¾ä»°Ð´ÔÚÕâÀïÊÇʲôÒâ˼£¿Ã»ÓÐÀûÒæÕùÒ飬¾Í»áÔÚÎÄÕÂÖгöÏÖ¡°×÷ÕßÐû´«Ã»ÓÐÀûÒæÕùÒ顱£¿


3. Additional Items:  
1. The Contribution contains third party material requiring permission. (Please forward all permission agreements to the editorial office within five (5) days after signing this Agreement).µÚÈý·½²ÄÁÏ£¬Õâ¸öÎÒûÓР        Yes          No
2. If Contributor answered ¡®Yes¡¯ to any question in Section 2 above, Contributor has explained each answer by providing additional information for each item in the box provided.Yes          N/A Èç¹ûÎÒÉÏÃæµÄÈκÎÒ»¸öÎÊÌâÑ¡ÔñÁËyes£¬ÎÒ±£Ö¤¶Ôÿ¸öÎÊÌâ¶¼ÌṩÁËһЩÐÅÏ¢À´ËµÃ÷¡£ÎÒÓ¦¸ÃÑ¡yes°É£¿         

For information about the fee-based SAGE Choice publishing option, please visit SAGE's website at: SAGE Choice FAQ.


By signing below, Contributors acknowledge their agreement to the above provisions and the terms and conditions stated in the ¡°Terms of the Agreement.¡± Contributors warrant that they have completed all information accurately and thoroughly. By signing this Agreement on behalf of all Contributors, Corresponding Contributor represents and warrants that he/she has received written permission from each Contributor to sign this Agreement on his or her behalf and to grant the exclusive license herein.Õâ¾ä»°µÄÒâ˼ÊDz»ÊÇÔÚÏÂÃæµç×ÓÇ©ÃûÒԺ󣬾ʹú±íÁËͨѶ×÷Õß»ñµÃÁËÿλ×÷ÕßµÄÊéÃæÍ¬Ò⣿

Corresponding Contributor understands that he/she has the option of having each Contributor sign a separate copy of this Agreement by contacting xxµç×ÓÓʼþµØÖ· for a version of this Agreement to be signed by each Contributor and returned directly to the Editorial Office.Õâ¾ä»°µÄÒâ˼ÊDz»ÊÇ¿ÉÒÔͨ¹ý·¢ÓʼþµÄ·½Ê½ÒªÀ´Èô¸ÉͬÒâÊ飬ÈÃÿ¸ö×÷Õßµ¥¶ÀÇ©Ãû£¬ÔÙ·¢»Ø±à¼­²¿£¿Õâ¸ö×ö·¨ÊDZØÐëÕâÑù»¹ÊÇ¿ÉÒÔÑ¡ÔñµÄ£¨option£©ÄØ£¿

By Contributor: (to sign this agreement, please enter your name below)ÕâÀïÊDZØÐëÿ¸ö×÷Õß¶¼°Ñ×Ô¼ºµÄÃû×Ö¶¼ÊäÈë½øÈ¥£¬»¹ÊÇÖ»ÒªÊäÈëͨѶ×÷ÕßµÄÃû×Ö£¿
Signed:           Õâ         Date:          


¸÷λսÓÑ£¬±¾È˵ÄÎÊÌâÓеã¶à£¬²»ºÃÒâ˼£¬Ï£Íû´ó¼Ò°ï棬ÔٴθÐл£¡
»Ø¸´´ËÂ¥
¼ÓÓÍ
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

pxiao08

Ìú³æ (³õÈëÎÄ̳)

¸÷λ³æÓÑ£¬°ï°ïæ°É¡£
¼ÓÓÍ
2Â¥2013-04-01 10:28:58
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ pxiao08 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼²©] ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O.55.1.O.5.4,¿ÆÄ¿È«,¿É+¼± +3 Qj98d49dHFb9 2026-08-25 5/250 2026-08-26 04:57 by cNXvBfCpiZOM
[ÂÛÎÄͶ¸å] ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8O.55.1.O.5.4,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 7K1CJE38xLG4 2026-08-25 4/200 2026-08-26 02:04 by cNXvBfCpiZOM
[»ù½ðÉêÇë] ½ñÌìÎñί»á¿ªÍêÁË£¬Ã÷Ìì³ö½á¹ûÂð +18 angus9576 2026-08-25 22/1100 2026-08-26 00:41 by merchancy
[»ù½ðÉêÇë] Ã÷ÌìÓ¦¸Ã¿É²éÁË£¡£¿ +6 chengyan1220 2026-08-23 6/300 2026-08-25 19:45 by zfd97
[»ù½ðÉêÇë] ·Å°ñǰµÄ²»µ­¶¨ 20+4 snowwithsea 2026-08-19 19/950 2026-08-25 17:57 by chick875
[»ù½ðÉêÇë] ijЩ»ú¹¹£¬ÒÔЧÂʵÍΪÈÙ£¬ÒÔЧÂʵÍ×÷Ϊ´æÔڸР+9 yuleib84 2026-08-25 10/500 2026-08-25 17:14 by alexon
[»ù½ðÉêÇë] ½ñÈÕ²»·Å°ñ£¿Íø´«¹ú×ÔȻԤ¼Æ 8 Ô 27 Èտɲé½á¹û +17 ҽѧÀÏÄк¢ 2026-08-20 22/1100 2026-08-25 15:36 by ҽѧÀÏÄк¢
[»ù½ðÉêÇë] Èç¹û´Ë¿ÌÄãÕýÔÚΪ¹ú»ù¸Ðµ½½¹ÂÇ£¬²»·ÁÀ´ÌýÌýÕâÊס¶»ù½ðÖ®Íâ¡· +8 scalable 2026-08-24 8/400 2026-08-25 12:52 by jnhyjjm
[»ù½ðÉêÇë] ÈËÆø²»ÐÐÁË +11 fansofjerry 2026-08-21 11/550 2026-08-25 11:04 by ¹Â¶ÀµÄÓ¢ÐÛ6
[»ù½ðÉêÇë] ½ñÌì»ù½ð»á³ö½á¹ûÂð£¿20260819 +17 kkkl_v 2026-08-19 18/900 2026-08-25 09:41 by windflowerwy
[»ù½ðÉêÇë] ÎÒÃæÉÏÍêµ°ÁË +13 ÇÒÌý»¢Ð¥ 2026-08-20 14/700 2026-08-25 09:10 by mrkang
[»ù½ðÉêÇë] ·¶½øÖоÙÒ»ÎĵÄÖÐÐÄ˼Ïë +7 Ñ׻ƹóëÐ 2026-08-22 8/400 2026-08-25 08:48 by ZJTJZ
[»ù½ðÉêÇë] Ö»ÓÐÿÄêÕâÖÖʱºòÀ´¹ä¹äСľ³æ +25 yaoyewhu2008 2026-08-20 27/1350 2026-08-25 08:01 by Equinoxhua
[»ù½ðÉêÇë] ÄÜ·ñÍ˳ö²ÎÓëµÄÃæÉÏÏîÄ¿½â³ýÏÞÏî +21 koalala 2026-08-24 24/1200 2026-08-24 19:25 by ¼ÒÓëÔ¶·½
[»ù½ðÉêÇë] filecode£¬4¸öjtjcÁË +14 ziyangfang 2026-08-19 17/850 2026-08-24 18:37 by ¹þ¹þ¸ò£¿
[»ù½ðÉêÇë] ½¨Òé»ù½ð·¢²¼Ìáǰ¸ø³öÃ÷È·µÄʱ¼äµã +13 kulium 2026-08-21 16/800 2026-08-24 16:27 by superceng
[»ù½ðÉêÇë] ¿ÆÑй¶ùÌ«ÄÑÁË +18 ÎÒ4´ó°×²Ë 2026-08-20 19/950 2026-08-24 09:47 by ¿­¶÷¹ãÊ¢´ß»¯·ÖÎ
[½Ìʦ֮¼Ò] Ìø²ÛºóÔÚÑÐÏîÄ¿Ôõô°ì£¿ +5 ¼òµ¥»¯xn 2026-08-22 10/500 2026-08-23 12:38 by ¼òµ¥»¯xn
[»ù½ðÉêÇë] ½ñÌì·Å°ñÂ𣿠+15 ²¼²¼ºÍÒ»¶þ 2026-08-19 16/800 2026-08-23 09:55 by ÕÅ´ºÉú
[»ù½ðÉêÇë] ¿´À´½ñÌì²»»á·Å°ñÁË£¿ +8 chengyan1220 2026-08-21 11/550 2026-08-21 17:52 by dcqxinyang
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û